108
Views
27
CrossRef citations to date
0
Altmetric
Research Article

Successful treatment with doxycycline and nicotinamide of two cases of persistent pemphigoid gestationis

, , , , &
Pages 143-146 | Published online: 12 Jul 2009

  • Kelly SE. Black MM. Flemmy S. Pemphigoid gestationis. J Pathol(1989) 158:81-8.
  • ShornickJK, Herpes gestationis. J Am Acad Dermatel (1987) 17: 539-56.
  • Yancey KB, Herpes gestationis. Dermatol Clin (1990) 8: 727-35.
  • Fabbri P, Herpes gestationis. In: Pemtigoidi I (ed) Monografie dermatologiche. SIGRED): Florence, 1993, pp. 121-35.
  • Shornick JK, Herpes gestationis. Dermatol Clin (1993) 11: 527-33.
  • Holmes RC, Black MM, Jureka W, Clues to the aetiology and pathogenesis of herpes gestationis. Br J Dermatol (1983) 109:131-9.
  • Holmes RC, Williamson DM, Black MM, Herpes gestationis persisting for 12 years postpartum. Arch Dermatol (1986) 122: 375-6.
  • Fine J, Omura FF. Herpes gestationis: persistent disease activity 11 years post partum. Arch Dermatol (1985) 121: 924-6.
  • Castle SP, Mather-Mondrey M, Bennion S, Chronic herpes gestationis and antiphospholipid antibody syndrome successfully treated with cyclophosphamide. J Am AcadDermatol (1996) 34: 333-6.
  • Amato L, Mei S, Gallerani I, et al, A case of chronic herpes gestationis: persistent disease or conversion to bullous pemphigoidr/Am Acad Dermatol (2002: in press).
  • Berk MyV, Lorinez AL, The treatment of bullous pemphigoid with tetracycline and nicotinamide. Arch Dermatol (1986) 122: 670-4.
  • Lindemann C, Engstrom WW, Flynn RT, Herpes gestationis: results of treatment with adrenocorticotrophic hormone (ACTH) and cortisone. Am J Obstet Gynecol (1952)63:167-70.
  • Lawley TJ, Stingl G, Katz SI, Fetal and maternal risk factors in herpes gestationis. Arch Dermatol ( 1978) 114: 552-5.
  • Russel B, Thorne NA, Herpes gestationis. Br J Dermatol (1957)69: 339-57.
  • Fosnaugh RP, Bryan HG, Orders RL, Pyridoxine in the treatment of herpes gestationis. Arch Dermatol (1961) 84: 90-5.
  • Bushkell LL, Jordon RE, Goltz RW, Herpes gestationis: new immunologie findings. Arch Dermatol (1974) 110: 65-9.
  • Van de Weil A, Hart HC. Flinterman J, et al. Plasma exchange in herpes gestationis. Br Med J (1950) 281: 1041-2.
  • Carruthers JA. Ewins AR, Herpes gestationis: studies on the binding characteristics, activity and pathogenetic significance of complement-fixing factor. Clin Exp Iinmunol (1975) 31: 38-44.
  • Tindall JG, Rea TH. Shulman I, Quismorio P, Herpes gestationis in association with a hydatiform mole. Arch Dermatol (1981) 117: 510-12.
  • Jenkins RE, Hern S, Black MM. Clinical features and management of 87 patients with pemphigoid gestationis. Clin Exp Dermatol (1999) 24:2 5 5-9.
  • Jenkins RE. Vaughan Jones SA. Black MM. Conversion of pemphigoid gestationis to bullous pemphigoid - two refractory cases highlighting this situation. Br J Dermatol ( 1996) 135: 595-8.
  • MacDonald KJS. Raffle EJ. Ritodrine therapy associatedwith remission of pemphigoid gestationis. Br J Dermatol(1984) 111:630 (letter).
  • Fivenson DP. Breneman DL. Rosen GB. et al. Nicotinamideand tetracycline therapy of bullous pemphigoid. Arch Der-tnatol (1994) 130: 758-81.
  • KoIbach DN. Remme JJ. Bos WH. et al. Bullous pemphigoid successfully controlled by tetracycline and nicotinamide. Br J Dermatol (1991) 133: 88-90.
  • Homschuh B. Hamm H. Wever S. et al. Treatment of 16 patients with bullous pemphigoid with oral tetracycline and niacinamide and topical clobetasol. / Am Ac ad Dermatol (1997) 36:101-3.
  • Goon AT. Tan SH. Khoo LS, et al. Tetracycline and nicotinamide for the treatment of bullous pemphigoid: our experience in Singapore. Singapore Med J (2000) 41: 327-30.
  • Morrison LH. Anhalt GJ. Herpes gestationis. / Auto'immim (1991)4: 37-45.
  • Diaz LA. Ratrie H III. Saunders WS. Isolation of human epidermal cDNA corresponding to the 180-Id) antigen recognized by bullous pemphigoid and herpes gestationis sera Immunolocalization of this protein to the emidesmosome. / Clin Invest (1990) 86:1088-94.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.